Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_research_1.jpg?itok=p7pBtlZR)
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment.
Cell Death & Disease.
2022,
13(3),
203,
ISSN: 2041-4889,
PMID: 35246527,